These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25690588)

  • 1. The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines?
    Flink L; Underberg JA; Newman JD; Gianos E
    Curr Atheroscler Rep; 2015 Apr; 17(4):494. PubMed ID: 25690588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of dyslipidemia in HIV.
    Sekhar RV
    Curr Atheroscler Rep; 2015 Apr; 17(4):493. PubMed ID: 25702057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multimodal therapy of dyslipidemia].
    Stahn A; Hanefeld M
    Clin Res Cardiol Suppl; 2011 May; 6():10-6. PubMed ID: 22528173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric dyslipidemia: recommendations for clinical management.
    Wilson DP; McNeal C; Blackett P
    South Med J; 2015 Jan; 108(1):7-14. PubMed ID: 25580750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
    Gorkin JU; Watson K; Knopp RH
    J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia.
    Dake AW; Sora ND
    Am J Med Sci; 2016 Apr; 351(4):361-5. PubMed ID: 27079341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid management in the geriatric patient.
    Nair AP; Darrow B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertriglyceridemia: A review of the evidence.
    Elkins C; Friedrich D
    Nurse Pract; 2018 Oct; 43(10):22-29. PubMed ID: 30153192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving concepts on benefits and risks associated with therapeutic strategies to raise HDL.
    Shah PK
    Curr Opin Cardiol; 2010 Nov; 25(6):603-8. PubMed ID: 20827180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.
    Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
    J Clin Lipidol; 2014; 8(5):473-88. PubMed ID: 25234560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
    Ito MK
    Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (8) Cardiovascular disease and risk management.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S49-57. PubMed ID: 25537708
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid-lowering medications for children and adolescents.
    Miller ML; Wright CC; Browne B
    J Clin Lipidol; 2015; 9(5 Suppl):S67-76. PubMed ID: 26343214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2016 European Society of Cardiology guidelines for the management of dyslipidemias].
    Ferrières J
    Presse Med; 2017; 46(7-8 Pt 1):688-696. PubMed ID: 28502376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
    Jacobson TA
    Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy for dyslipidemia.
    Sharma M
    Curr Opin Cardiol; 2011 Sep; 26(5):420-3. PubMed ID: 21832894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Essence of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version and Treatment Guide for Dyslipidemia 2013--Current Strategy for the Lipid Assessment].
    Arai H
    Rinsho Byori; 2014 Sep; 62(9):878-83. PubMed ID: 27526533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HDL, or non-HDL: that is the question. Possibilities of pharmacological treatment in residual dyslipidaemia].
    Bajnok L
    Orv Hetil; 2014 Jan; 155(2):62-8. PubMed ID: 24389322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for the management of dyslipidemia].
    Díaz Rodríguez Á;
    Semergen; 2014 Sep; 40 Suppl 4():19-25. PubMed ID: 25595349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.